Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Foamix Pharmaceuticals logo — company profile

Foamix Pharmaceuticals

Founded 2003 Israel Israel 31 employees Post-IPO Debt Health Care, Pharmaceutical

General Information

Company Name Foamix Pharmaceuticals
Founded Year 2003
Location Israel Israel
Employees 31
Industries Health Care, Pharmaceutical
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Foamix Pharmaceuticals. To contact Foamix Pharmaceuticals, visit foamix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Foamix Pharmaceuticals compare?

A PDF of Foamix Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Foamix Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Foamix Pharmaceuticals

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) is a clinical stage specialty pharmaceutical company founded in 2003, headquartered in Israel. The company is dedicated to developing and commercializing proprietary topical foams to address unmet needs in dermatology. Their innovative product candidates include FMX101, a novel minocycline foam designed for the treatment of moderate-to-severe acne, and FMX103 for the treatment of moderate-to-severe rosacea. With a focus on the Health Care and Pharmaceutical industries, Foamix Pharmaceuticals is positioned to make a significant impact in addressing dermatological concerns. As of now, there is no available information on their last investment or investors.

No funding data available for Foamix Pharmaceuticals yet.

Foamix Pharmaceuticals Alternatives & Competitors

View All Alternatives
Foamix Pharmaceuticals vs
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. United States

Translating cancer biology into medicines.

Post-IPO Equity
12 employees
Biotechnology, Health Care
Foamix Pharmaceuticals vs
Tetralogic Pharmaceuticals
Tetralogic Pharmaceuticals

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on d...

Convertible Note
10 employees
Biotechnology, Health Care
Foamix Pharmaceuticals vs
Xanodyne Pharmaceuticals
Xanodyne Pharmaceuticals United States

Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company w...

Venture round
50 employees
Biotechnology, Health Care
Also compare with: Foamix Pharmaceuticals vs ASLAN Pharmaceuticals ASLAN Pharmaceuticals View all alternatives

FAQ About Foamix Pharmaceuticals

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment...
Foamix Pharmaceuticals was founded in 2003.
Foamix Pharmaceuticals is headquartered in Israel.
Foamix Pharmaceuticals operates in Health Care and Pharmaceutical.
Foamix Pharmaceuticals has approximately 31 employees.
Top alternatives and competitors to Foamix Pharmaceuticals include Cyclacel Pharmaceuticals, Inc., Tetralogic Pharmaceuticals, Xanodyne Pharmaceuticals, Aegera Therapeutics Inc., Transport Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Foamix Pharmaceuticals and Cyclacel Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Foamix Pharmaceuticals, https://bouncewatch.com/company/foamix-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout